Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
104.19
+3.08 (3.05%)
Jun 9, 2026, 4:00 PM EDT - Market closed

Encompass Health Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Encompass Health stock has a consensus rating of "Strong Buy" and an average price target of $140.5. The average 1-year stock price forecast is 34.85% higher than the current stock price, while the lowest is $125 (+19.97%) and the highest is $152 (+45.89%).

Price Target: $140.5 (+34.85%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$125$140.5$140$152
Change+19.97%+34.85%+34.37%+45.89%

Analyst Ratings

The average analyst rating for Encompass Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingDec '25Jan '26Feb '26Mar '26Apr '26May '26
Strong Buy111111111112
Buy221111
Hold000000
Sell000000
Strong Sell000000
Total131312121213

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Buy
Initiates
$125
BuyInitiates$125+19.97%May 28, 2026
Bank of America Securities
Bank of America Securities
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 13, 2026
Barclays
Barclays
Buy
Maintains
$153$140
BuyMaintains$153$140+34.37%May 5, 2026
William Blair
William Blair
Buy
Maintains
n/a
BuyMaintainsn/an/aMay 4, 2026
Unknown Analyst
Stephens
No rating
Stephens
Buy
Reiterates
$140
BuyReiterates$140+34.37%May 4, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
6.42B
from 5.94B
Increased by 8.20%
Revenue Next Year
6.94B
from 6.42B
Increased by 8.13%
EPS This Year
6.01
from 5.45
Increased by 10.25%
EPS Next Year
6.54
from 6.01
Increased by 8.81%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
4.01B4.35B4.80B5.37B5.94B6.42B
Revenue Growth
12.58%8.31%10.41%11.91%10.46%8.20%
Gross Profit
1.70B1.75B1.98B2.23B2.56B2.69B
Gross Margin
42.43%40.32%41.30%41.56%43.22%41.90%
Operating Income
659.40M630.20M731.80M874.90M1.05B1.01B
Net Income
412.20M271.00M352.00M455.70M566.20M621.97M
EPS
----5.456.01
EPS Growth
----23.02%10.25%
Forward PE
14.9918.9518.1220.0918.9117.34
Dividend / Share
1.120.860.600.640.720.77
Dividend Growth
--23.21%-30.23%6.67%12.50%6.48%
Free Cash Flow
-73.86M-3.34M123.69M215.84M296.79M409.72M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High6.4B
Avg6.4B
Low6.4B

Revenue Growth

Revenue Growth202620272028
High
8.4%
Avg
8.2%
Low
7.8%

EPS Forecast

EPS202620272028
High-
Avg6.01
Low-

EPS Growth

EPS Growth202620272028
High-
Avg
10.2%
Low-